New Technology– category –
-
AI Accelerates Gene Editing Tool Development: Profluent Unveils OpenCRISPR-1, First AI-Designed Open-Source CRISPR, Heralding a New Era of Genomic Medicine
Facebook USA Overview Artificial intelligence is dramatically accelerating the development of gene editing tools. Profluent announced OpenCRISPR-1, the first AI-designed open-source gene editor, merging CRISPR technology with large langu... -
IPS HEART’s iPSC-Derived Cell Therapy ISX9-CPC Secures FDA Rare Pediatric Disease Designation, Advancing Clinical Trials for Cardiac & Rare Muscle Disorders
Facebook (IPS Heart) USA Overview IPS HEART announced that its iPSC-derived cell therapy, ISX9-CPC, received Rare Pediatric Disease Designation (RPDD) from the FDA. Targeting cardiac and rare muscle disorders, this designation positions ... -
Sickle Cell Gene Therapy Breakthrough: Broad Institute’s Base Editing Permanently Resolves Disease in 42 Patients; FDA Approval & Stanford Trial Expansion Underway
Facebook (Stanford Medicine) USA Overview In a significant advance for sickle cell disease (SCD) gene therapy, Broad Institute's base editing therapy has permanently resolved SCD in 42 patients, with 24-month follow-up data reported. Con... -
CRISPR/Cas9 Evolves into Multi-Tool: Expanding Applications from Leukemia Screening to CAR-T Cell Engineering and Epigenome Editing
NHSJS USA Overview CRISPR/Cas9 technology has significantly evolved, broadening its applications from screening leukemia mutations to enhancing CAR-T cells' cancer recognition and precisely controlling gene expression through epigenome e... -
CRISPR Frontiers 2026: Innovations in DSB-Independent Editing and Delivery Systems Boost Genome Editing Precision and Stability
Addgene Blog USA Overview The 'Genome Engineering: CRISPR Frontiers 2026' conference reported significant evolution in CRISPR technology towards precise, double-strand break (DSB)-independent editing. Researchers are focusing on enhancin... -
Next-Generation CRISPR Tools Revolutionize Precise Gene Editing, Bypassing Double-Strand Breaks for Enhanced Therapeutic Safety and Consistency
News-Medical.net USA Overview Next-generation CRISPR technologies are fundamentally transforming cell and gene therapy by enabling precise gene editing without relying on double-strand DNA breaks (DSBs). Advances in base editing, prime e... -
AI-Discovered Drugs Advance: Insilico Medicine’s Rentosertib Enters Phase III, But Fully AI-Designed Drugs Await Approval (As of 2026)
Life Science Daily News Global Overview As of 2026, AI-generated pharmaceuticals are rapidly advancing through clinical development, with Insilico Medicine's Rentosertib reaching Phase III trials—a significant milestone for AI drug disco... -
US FDA Launches Discussion on Generative AI Medical Device Regulatory Framework, Covering Risk Assessment and Post-Market Surveillance
Regulations.gov (via US FDA) USA Overview The US FDA released its first discussion paper on a federal regulatory framework for generative AI-enabled medical devices, soliciting public comments on approaches for risk assessment, pre-marke... -
Vertiv Bolsters AI Infrastructure with Major Italian Investment, Doubling Chiller Production by 2026
AINewsWire Italy Overview Vertiv Holdings has announced a significant strategic investment in its Tognana, Italy campus to dramatically expand data center cooling system manufacturing. This initiative will double chiller production capac... -
Generate:Biomedicines Discloses Early Clinical Data for AI-Discovered Respiratory Drug Candidate After Poster Leak
Endpoints News USA Overview Generate:Biomedicines formally disclosed early clinical data for its AI-discovered respiratory drug candidate following an accidental congress poster leak. This data marks the first concrete clinical trial ind...
